Summary
Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K on January 12, 2004, to disclose information regarding its 2003 accomplishments and its financial outlook for 2004. The report primarily references a press release issued on January 12, 2004, which contains the detailed information. Investors should note that this filing itself does not contain extensive financial data but serves as a notification that a press release with results and guidance has been disseminated.
Key Highlights
- 1Vertex Pharmaceuticals issued an 8-K filing on January 12, 2004.
- 2The filing's primary purpose is to report on 2003 accomplishments.
- 3The press release attached (Exhibit 99.1) reiterates Vertex's full-year 2003 financial guidance.
- 4The press release also provides Vertex's outlook for 2004.
- 5The information provided in this 8-K is not considered 'filed' for the purposes of Section 18 of the Exchange Act.
- 6The filing serves as a reference point for investors to access the detailed press release for financial performance and future guidance.